Home » MCRI FORMS STRATEGIC ALLIANCE WITH QAS FOR SELF-MONITORING OF ANTICOAGULATION BY ON-X HEART VALVE PATIENTS
MCRI FORMS STRATEGIC ALLIANCE WITH QAS FOR SELF-MONITORING OF ANTICOAGULATION BY ON-X HEART VALVE PATIENTS
Medical Carbon Research Institute L.L.C. (MCRI®), manufacturer of the On-X® prosthetic heart valve, today announced the formation of a strategic alliance with Quality Assured Services, a leading provider of anticoagulation monitoring products and services, to promote the use of anticoagulation self monitoring by recipients of the On-X valve. QAS will provide the ProTime® system from ITC for patient self monitoring and the feedback system that allows physicians to oversee treatment and data capture.
Yahoo News (http://biz.yahoo.com/prnews/050823/sftu028.html?.v=23)
KEYWORDS FDAnews Device Daily Bulletin
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May